Inhibitory effects of clozapine and other antipsychotic drugs on noradrenaline transporter in cultured bovine adrenal medullary cells

Psychopharmacology

Volumn 149, Issue 1, 2000, Pages 17-23

  Yoshimura, Reiji ^a   Yanagihara, Nobuyuki ^a   Hara, Koji ^a   Terao, Takeshi ^a   Nakamura, Jun ^a   Ueno, Susumu ^a   Toyohira, Yumiko ^a   Uezono, Yasuhito ^a   Kaneko, Shigeru ^a   Kawamura, Masaru ^a   Abe, Kazuhiko ^a   Izumi, Futoshi ^a  

^a UNIVERSITY OF OCCUPATIONAL AND ENVIRONMENTAL HEALTH   (Japan)

Author keywords

Adrenal medullary cell; Antipsychotic drug; Clozapine; Noradrenaline transporter; 3H Desipramine binding; 3H Noradrenaline uptake

Indexed keywords

CARRIER PROTEIN; CHLORPROMAZINE; CLOZAPINE; DESIPRAMINE; HALOPERIDOL; NEUROLEPTIC AGENT; NORADRENALIN; NORADRENALIN TRANSPORTER; RISPERIDONE; TRICYCLIC ANTIDEPRESSANT AGENT; UNCLASSIFIED DRUG;

ADRENAL MEDULLA; ANIMAL CELL; ARTICLE; CATTLE; CELL MEMBRANE; CONTROLLED STUDY; DRUG BINDING; DRUG BLOOD LEVEL; DRUG MECHANISM; NONHUMAN; NORADRENALIN RELEASE; PRIORITY JOURNAL; PSYCHOSIS; SCHIZOPHRENIA; XENOPUS LAEVIS;

EID: 0034079545     PISSN: 00333158     EISSN: None     Source Type: Journal    
DOI: 10.1007/s002139900339     Document Type: Article

References (35)

1. Ackenheil M (1989) Clozapine:pharmacokinetic investigation and biochemical effects. Psychopharmacology 99:32-37
2. Aravagiri M, Marder SR, Wirshing D, Wirshing WC (1988) Plasma concentrations of risperidone and its 9-hydroxy metabolite and their relationship to dose in schizophrenic patients: simultaneous determination by high performance liquid chromatography with electrochemical detection. Pharmacopsychiatry 31: 102-109
3. Ashby CR Jr, Wang RY (1996) Pharmacological actions of the atypical antipsychotic drug clozapine: a review. Synapse 24: 349-394
4. Barker EL, Blakely RD (1995) Norepinephrine and serotonin transporters. Molecular targets of antidepressant drugs. In: Bloom FE, Kupfer DJ (eds) Psychopharmacology: a fourth generation of progress. Raven Press, New York, pp 321-333
5. Bönisch H, Brüss M (1994) Catecholamine transporter of the plasma membrane. In: Wiedermann B, Kvols LK, Arnold, Riecken EO (eds) Molecular aspects of gastroenteropancreatic neuroendocrine tumor disease. Ann NY Acad Sci 733:193-202
6. Breier A (1994) Clozapine and noradrenergic function: support for a novel hypothesis for superior efficacy. J Clin Psychiatry Suppl B 55:122-125
7. Breier A, Buchanan RW, Waltrip RW II (1994) The effects of clozapine on plasma norepinephrine: relationship to clinical efficacy. Neuropsychopharmacology 10:1-7
8. Brüss M, Hammermann R, Bönish H (1995) Antipeptide antibodies confirm the topology of the human norepinephrine transporter. J Biol Chem 270:9197-9201
9. Buck KJ, Amara SG (1994) Chimeric dopamine-norepinephrine transporters delineate structural domains influencing selectivity for catecholamine and 1-methyl-4-phenylpyridinium. Proc Natl Acad Sci USA 91:12584-12588
10. Carboni E, Tanda GL, Frau R, Di Chiara G (1990) Blockade of the noradrenaline carrier release increases extracellular dopamine concentration in the prefrontal cortex: evidence that dopamine is taken up in vivo by noradrenergic terminals. J Neurochem 55:1067-1070
11. 3H]-noradrenaline by cultured chromaffin cells. Br J Pharmacol 81:119-123
12. Garattini S, Morselli PL (1978) Metabolism and pharmacokinetics of psychotropic drugs. In: Clark WG, del Giudice J (eds) Principles of psychopharmacology, 2nd edn. Academic Press, New York, pp 169-182
13. Giros B, Wang YM, Suter S, McLeskey SB, Pifl C, Caron MG (1994) Delineation of discrete domains for substrate, cocaine, and tricyclic antidepressant interaction using chimeric dopamine-norepinephrine transporters. J Biol Chem 269:15985-15988
14. Green AI, Alam MY, Sobieraj JT (1993) Clozapine response and plasma catecholamines and their metabolites. Psychiatry Res 46:139-149
15. Gresch P, Sved AF, Zigmond MJ, Finlay J (1995) Local influence of endogenous norepinephrine on extracellular dopamine in the rat medial prefrontal cortex. J Neurochem 65:111-116
16. Groß G, Schumann HJ (1980) Enhancement of noradrenaline release from rat cerebral cortex by neuroleptic drugs. Naunyn-Schmiedeberg's Arch Pharmacol 315:103-109
17. Hasegawa M, Gutierrez-Esteinou R, Way L, Meltzer HY (1993) Relationship between clinical efficacy and clozapine plasma concentrations in schizophrenia: effect of smoking. J Clin Psychopharmacol 13:383-390
18. Kenigsberg RL, Trifaro JM (1980) Presence of a high affinity up-take system for catecholamines in cultured bovine adrenal chromaffin cells. Neuroscience 5:1547-1556
19. Klimek V, Rajkowska G, Luker SN, Dilley G, Meltzer HY, Overholser JC, Stockmeier CA, Ordway GA (1999) Brain noradrenergic receptors in major depression and schizophrenia. Neuropharmacology 21:69-81
20. Leysen JE, Gommeren W, Eens A, de Chaffoy D, de Courcelles, Stoof JC, Janssen PAJ (1988) Biochemical profile of risperidone, a new antipsychotic. J Pharmacol Exp Ther 247: 661-670
21. Leysen LE, Janssen PM, Heylen L, Gommeren W, van Gompel P, Lesage AS, Megens AA, Schotte A (1998) Receptor interactions of new antipsychotics: relation to pharmacodynamic and clinical effects. Int J Psychiatr Clin Pract 2:3-17
22. Lingen B, Bruss M, Bonisch H (1994) Cloning and expression of the bovine sodium and chloride-dependent noradrenaline transporter. FEBS Lett 342:235-238
23. Marder SR (1998) Antipsychotic medications. In: Schatzberg AF, Nemeroff CB (eds) Textbook of psychopharmacology, 2nd edn. American Psychiatric Press, Washington, D.C., pp 309-321
24. Marder SR, Hubbard JW, Van Putten T (1989) Pharmacokinetics of long-acting injectable neuroleptic drugs: clinical implications. Psychopharmacology 98:433-439
25. 3H]-desipramine binding site of the bovine adrenomedullary plasma membrane. Naunyn-Schmiedeberg's Arch Pharmacol 346:203-207
26. Owens M, Risch SC (1998) Atypical antipsychotics. In: Schatzberg AF, Nemeroff CB (eds) Textbook of psychopharmacology, 2nd edn. American Psychiatric Press, Washington, D.C., pp 323-348
27. Pacholczyk T, Blakely RD, Amara SG (1991) Expression cloning of a cocaine-and antidepressant-sensitive human noradrenaline transporter. Nature 350:350-354
28. Perry PJ, Miller DD, Arndt SV, Cadoret RJ (1991) Clozapine and norclozapine plasma concentrations and clinical response of treatment-refractory schizophrenic patients. Am J Psychiatry 148:231-235
29. Pickar D, Owen RR, Litman RE (1992) Clinical and biologic response to clozapine in patients with schizophrenia: crossover comparison with fluphenazine. Arch Gen Psychiatry 49: 345-353
30. Tanda G, Carboni E, Frau E, Di Chiara G (1994) Increase of extracellular dopamine in the prefrontal cortex: a trait of drugs with antidepressant potential? Psychopharmacology 115:285-288
31. Ueno S, Kusaba M, Takeda K, Maeda M, Futai M, Izumi F, Kawamura M (1995) Functional consequences of substitution of the disulfide-bounded segment, Cyc127-Cys150, located in the extracellular domain of the Na, K-ATPase β subunit: Arg148 is essential for the functional expression of Na, K-ATPase. J Biochem 117:591-595
32. Westerink BHC, de Boer P, de Vries JB, Kruse CG, Long SK (1998) Antipsychotic drugs induce similar effects on the release of dopamine and noradrenaline in the medial prefrontal cortex of the rat brain. Eur J Pharmacol 361:27-33
33. Yanagihara N, Isosaki K, Ohuchi T, Oka M (1979) Muscarinic receptor-associated increase in cyclic GMP level in isolated bovine adrenal medullary cells. FEBS Lett 105:296-298
34. Yanagihara N, Minami K, Shirakawa F, Uezono Y, Kobayashi H, Eto S, Izumi F (1994) Stimulatory effect of IL-1β on catecholamine secretion from cultured bovine adrenal medullary cells. Biochem Biophys Res Commun 198:81-87
35. 2+ in cultured bovine adrenal medullary cells. J Biol Chem 275:17463-17468